Magnitude Biosciences Ltd published the second chapter of its end-to-end Case Study series titled From Molecule to Mechanism, detailing the discovery and characterization of UrolithinA and its effects on healthspan.
Public source
Publisher name
Public post
📢 Watch this space! The second chapter of our end-to-end Case Study series begins: 💊 ➜ 🔬➜ ⚙️ From Molecule to Mechanism For companies looking to expand a candidate co…
Company
Magnitude Biosciences Ltd
Accelerating R&D with In Vivo C. elegans Data & WormGazer® Technology, De-Risking Clinical Trials and Cutting Costs
- Industry
- Biotechnology Research
- Location
- Durham, GB
- Company size
- 11–50 employees
About Magnitude Biosciences Ltd
An innovative C. elegans company, using our expertise and technology to provide quantified non-invasive assays of health outcomes for biotech, nutrition and other industries and research interests. - Prescreen compounds to reduce the number of experiments in mammals - Find effective and safe concentration ranges - Test mutants in signalling pathways - Screen libraries of mutants - Screen compound libraries - Combine compounds and mutants - Adapt technology to address your questions We are a team of experts with a proven track record of: Designing customised C. elegans studies to provide answers to your specific ageing research questions Integrating C. elegans into drug discovery pipelines Working with innovative biotech and pharma companies Providing relevant, standardised, data rich assays
See moreLatest activity
Latest activity from Magnitude Biosciences Ltd
8 signals
Presence & Recognition
Magnitude Biosciences Ltd is a sponsor of the 75th Annual Scientific Meeting of the British Society for Research on Ageing (BSRA) at Keble College, Oxford, from 9 to 11 September 2026, with Principal Scientist Dr Karthik Mohanraj attending.
Research & Knowledge
Magnitude Biosciences Ltd used the VivoScan whole-organism phenotypic screening platform to test lifespan-extending effects of Urolithin A in a wide range of concentrations.
Research & Knowledge
Magnitude Biosciences Ltd tested Urolithin A on WormGazer and found that its beneficial effects extended into overall organismal healthspan, preserving the quality of worms' mobility well into adulthood.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
DARWIN Bioprospecting Excellence
DARWIN Bioprospecting Excellence published a study by researchers using C. elegans as an ageing model to test how a specific magnetic bacterium increases lifespan.
Research & Knowledge
BioLight Labs
BioLight Labs published new research in Nature showing that late-life semaglutide extended lifespan in female mice by approximately 12% while improving markers of healthspan.
Research & Knowledge
NeuroAge Therapeutics
NeuroAge Therapeutics published a new paper in Nature out of Danica Chen's lab at Berkeley showing that Ozempic extends lifespan in mice.
Research & Knowledge
A BetterLife Pharma
A BetterLife Pharma published a Nature paper showing that semaglutide treatment in late-middle-aged female mice slowed biological hallmarks of aging, improved cognitive and motor performance, and extended median lifespan by roughly 12 percent.
Research & Knowledge
Standard Model Biomedicine